Depression and smoking are common comorbid conditions among adults with chronic pain. The aim of this study was to determine the independent effects of depression on clinical pain and opioid use among patients with chronic pain according to smoking status. A retrospective design was used to assess baseline levels of depression, clinical pain, opioid dose (calculated as morphine equivalents), and smoking status in a consecutive series of patients admitted to a 3-week outpatient pain treatment program from September 2003 through February 2007. Depression was assessed using the Centers for Epidemiologic Studies-Depression scale, and clinical pain was assessed using the pain severity subscale of the Multidimensional Pain Inventory. The study cohort (n = 1241) included 313 current smokers, 294 former smokers, and 634 never smokers. Baseline depression (P = .001) and clinical pain (P = .001) were greater among current smokers compared to former and never smokers, and the daily morphine equivalent dose was greater among smokers compared to never smokers (P = .005). In multivariate linear regression analyses, baseline pain severity was independently associated with greater levels of depression, but not with smoking status. However, status as a current smoker was independently associated with greater opioid use (by 27 mg/d), independent of depression scores. The relationship between depression, smoking status, opioid use, and chronic pain is complex, and both depression and smoking status may be potentially important considerations in the treatment of patients with chronic pain who utilize opioids.This study found that pain severity was associated with greater depression but not smoking; however, smoking was associated with greater opioid use, independent of depression. Ó
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Introduction
Symptoms of depression are common among smokers with chronic pain. In a prospective study that involved adults with chronic pain admitted to a 3-week outpatient pain rehabilitation program, smokers reported significantly greater levels of depression at baseline compared to nonsmokers [30] . Other studies of adults with chronic pain support the observation that levels of depression are consistently greater among smokers compared to nonsmokers [71, 72] . In addition to greater levels of depression, smokers with chronic pain also experience greater levels of pain. In a study that utilized a standardized composite measure of pain, smokers presenting to a pain rehabilitation program had significantly greater pain scores compared to former and never smokers [32] . Similarly, elevated levels of pain intensity assessed using a numerical rating scale have been observed among smokers compared to nonsmokers with chronic pain in some, but not all studies [16, 24, 71, 72] . The frequency of opioid use has been found to be greater among smokers, and these patients consumed significantly greater dosages compared to former and never smokers with chronic pain [31, 32] .
Increased levels of pain and opioid use in smokers could be due, in part, to the acute effects of nicotine or the consequences of chronic nicotine exposure. Elevated levels of depression could also contribute to increased pain and opioid use in smokers. These links are supported by epidemiologic studies that have identified a reciprocal relationship between depression and the development of chronic pain [10, 14, 15] . Similarly, experimental pain studies have demonstrated associations between depression and pain [2, 17] , and patients with depressive symptoms have been reported to be less responsive to opioid analgesia [68, 69] . However, the complex relationships between depression, pain, opioid use, and smoking status have not been elucidated. Such knowledge would be
